Education
About Us
Working with TipRanks
Follow Us
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
RESEARCH TOOLSreports
ESLA Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ESLA Stock 12 Month Forecast
Average Price Target
$16.00
▲(2005.26% Upside)
| Highest Price Target$16.00 | Average Price Target$16.00 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
D. Boral Capital
Initiated
02/18/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
D. Boral Capital
Initiated
02/18/25
ESLA Analyst Recommendation Trends
Rating
Feb 25
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
Each month's total comprises the sum of three months' worth of ratings.
ESLA Financial Forecast
ESLA Stock Forecast FAQ
What is ESLA’s average 12-month price target, according to analysts?
Based on analyst ratings, Estrella Immunopharma’s 12-month average price target is $16.00.
What is ESLA’s upside potential, based on the analysts’ average price target?
Estrella Immunopharma has 2005.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ESLA a Buy, Sell or Hold?
Estrella Immunopharma has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Estrella Immunopharma’s price target?
The average price target for Estrella Immunopharma is $16.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.00 ,the lowest forecast is $16.00. The average price target represents 2005.26% Increase from the current price of $0.76.
The highest analyst price target is $16.00 ,the lowest forecast is $16.00. The average price target represents 2005.26% Increase from the current price of $0.76.
What do analysts say about Estrella Immunopharma?
Estrella Immunopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of ESLA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.